Regions: North Slave Region
Tags: health, infants, hospitalization, acute respiratory infection
| Principal Investigator: | Goldfarb, David (3) |
| Licence Number: | 17037 |
| Organization: | University of British Columbia |
| Licensed Year(s): |
2023
2022
|
| Issued: | May 16, 2022 |
| Project Team: | Mai-Lei Kinshella, Darcy Scott, Michelle Dittrick |
Objective(s): To identify the respiratory infection admissions at all hospitals serving Nunavummiut children under one year of age from 2010-2020.
Project Description: This licence has been issued for the scientific research application No.5289. The research team propose to identify the respiratory infection admissions at all hospitals serving Nunavummiut children under one year of age from 2010-2020. The objectives of the study are to: 1) Determine the rate and outcome of infant respiratory infection hospitalizations; 2) Assess the effectiveness of the palivizumab vaccination program in preventing hospital admissions due to respiratory syncytial virus (RSV) infections in Nunavut; 3) Understand the factors associated with severe hospital stays due to respiratory tract infections; and 4) Assess the potential indirect impact of the COVID-19 pandemic measures on burden of infant admissions to hospital for respiratory infections The research team will review hospital charts at the six hospitals serving the population of Nunavut: Qikiqtani General Hospital, Stanton Territorial Hospital, Montreal Children’s Hospital, Children’s Hospital of Eastern Ontario, Winnipeg Children’s Hospital, and Stollery Children’s Hospital in Edmonton. The research team will engage public health, clinical and community partners in Nunavut and Northwest Territories throughout the research to identify appropriate ways to inform communities about the project and its outcomes. Methods of sharing results include dissemination teleconferences and a policy brief one pager. The fieldwork for this study will be conducted from May 13, 2022 to December 31, 2022
